Finpecia vs Propecia: A Practical Comparison

Both Finpecia and Propecia contain 1mg finasteride, a 5-alpha-reductase type 2 inhibitor first approved by the US FDA in 1992 for BPH and 1997 for androgenic alopecia. The mechanism — reducing the conversion of testosterone to DHT — is the same regardless of brand. Bioequivalence is the regulatory standard for generic substitution worldwide.

Cipla is one of India's largest pharmaceutical companies, founded in 1935. It operates WHO-GMP, EU-GMP, and USFDA-inspected facilities and supplies generic medications to more than 80 countries. Cipla's Propecia generic (Finpecia) has been the de facto worldwide reference for affordable finasteride for two decades. The same company makes its branded Propecia generic available across most international markets.

In the US, brand-name Propecia 1mg sells for $70–$100 per month at retail pharmacies. Generic finasteride 1mg from US pharmacies (post-2014 patent expiry) lands at $10–$20 per month. Finpecia from Cipla via international generic exporters runs $3–$8 per month ordered in 90-tablet (~3 month) packs. The price gradient reflects manufacturing scale and direct supply chain, not chemical difference.

• Choose Propecia if: you have insurance covering the brand, you prefer US-domestic supply, you want a doctor-managed monthly fill
• Choose US generic finasteride if: you want US-domestic supply at lower cost than brand
• Choose Finpecia if: you pay out-of-pocket, you want the lowest sustained price, you accept 2–3 week international transit, and your jurisdiction permits personal import

Finasteride works by blocking DHT conversion. Most users see hair-loss arrest within 3–6 months and visible regrowth (where it happens) within 6–12 months. If you discontinue, the protective effect fades within ~12 months and hair loss resumes its prior trajectory. Long-term continuous use is the design — the original Propecia clinical trials assumed indefinite use.

A small percentage of users report sexual side effects (decreased libido, erectile difficulty) that typically resolve on discontinuation. Post-finasteride syndrome (PFS) is debated, rare, and contested in the literature, but real to those affected. Pregnancy is a hard contraindication: handling crushed or broken tablets is a teratogenic risk to pregnant partners. Not for women.

Finasteride is not a controlled substance in any major Western jurisdiction. The US FDA permits personal importation under enforcement discretion, typically a 90-day supply. Similar frameworks in the UK, Canada, EU, Australia. Verify your country's rules.